Got $1,000? 2 Stocks to Own Before the Anthropic IPO.

The cleanest beneficiary is not the AI model company itself but the infrastructure layer with pricing power. AVGO should read as a higher-quality monetization path than the GPU complex because custom silicon revenue is stickier once a customer designs in, but the real upside is only partially in the next print — the bigger earnings inflection is 2026-27 when installed capacity turns into reported revenue. GOOGL gets a quieter second-order lift if TPU utilization rises, but that benefit is diluted if the customer eventually internalizes more of the stack; in that case, the cloud provider keeps the workload, while the chip economics migrate away from it.

The main risk is substitution, not demand. If the customer pushes toward in-house or alternate silicon, the market may be overestimating the durability of supplier capture, especially for a relationship concentrated in one fast-scaling account. The cadence matters: near term this is a sentiment tailwind, 1-3 months is about sell-side estimate revisions, and 6-18 months is about whether reported AI revenue can outrun the inevitable capex moderation that follows a massive buildout cycle. SPCX, if liquid enough, has the most binary setup because the cash-flow link is contractual, but it also carries the highest valuation and execution risk; one renegotiation or delay would hit it harder than AVGO.

Consensus may be missing that this is less an Anthropic IPO backdoor than a high-beta bet on continued circular AI spending. That makes the move somewhat overextended tactically: the market is likely already discounting the headline growth, while underappreciating how quickly customers will try to reduce dependency once volume is large enough. The falsifier is straightforward: any evidence of slower capacity ramp, chip insourcing, or reduced AI order intensity over the next two quarters should compress the supplier multiple even if the AI narrative remains intact.